JP Morgan Chase’s Boundless Bio BOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding BOLD
JP Morgan Chase's BOLD Position: Q3 2026 in Review
JP Morgan Chase increased its Boundless Bio (BOLD) stake by 553% in Q3 2026, buying an estimated $2.67K and bringing the position to 1,169 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #7399.
JP Morgan Chase first reported a position in BOLD in Q2 2024 and has held it in 9 quarters since. The position peaked at $229K in Q4 2024. 42 funds tracked by Wall St. Rank hold BOLD as of Q3 2026.
- JP Morgan Chase held 1,169 shares of Boundless Bio worth $2.99K as of Q3 2026.
- JP Morgan Chase bought 990 Boundless Bio shares in Q3 2026, an estimated $2.67K.
- Boundless Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7399 holding.
- JP Morgan Chase first reported a position in Boundless Bio in Q2 2024 and has held it in 9 quarters since.
- JP Morgan Chase's Boundless Bio position peaked at $229K in Q4 2024.
- 42 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.